Xenon Pharmaceuticals Inc (XENE)
R&D Expense Growth
12.11%
Quarterly · Period ending:
XENE R&D Expense Growth
Latest reported12.11%period ending
Latest reported12.11%period ending
XENE Quarterly R&D Growth (QoQ) (0.00% → 12.11%)
Latest values, visible window
High-resolution chart · PNG
XENE r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 12.1074% | |
| 0.9225% | |
| 13.815% | |
| 2.7592% | |
| 22.5245% | |
| 2.9056% | |
| 4.3918% | |
| 14.6232% | |
| 12.3209% | |
| 7.7271% | |
| -4.2071% | |
| -2.634% | |
| 11.4485% | |
| 13.4539% | |
| 18.3446% | |
| 32.8953% | |
| 14.3905% | |
| -11.5457% | |
| 15.8594% | |
| 2.797% | |
| 12.687% | |
| 8.9597% | |
| 14.7336% | |
| 21.6884% | |
| -9.0832% | |
| 0.3319% | |
| 20.521% | |
| 18.8422% | |
| -10.2003% | |
| 42.6319% | |
| 2.6603% | |
| 15.3846% | |
| -3.0824% | |
| -12.7716% | |
| -10.7063% | |
| 17.2696% | |
| 3.4898% | |
| 34.2812% | |
| -26.3034% | |
| 16.892% | |
| 16.934% | |
| 2.3692% | |
| 12.3912% | |
| 3.3797% | |
| 7.0616% | |
| -0.753% | |
| 7.3694% | |
| 25.3313% | |
| 1.3028% | |
| -7.6559% | |
| 6.4416% | |
| -26.1922% | |
| 0% | |
| 22.832% | |
| 0% | |
| 0% |